Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Antrafenine [INN]
RN: 55300-29-3
UNII: 21FS93Y6OE
InChIKey: NWGGKKGAFZIVBJ-UHFFFAOYSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C30-H26-F6-N4-O2

Molecular Weight

  • 588.549
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Antrafenine
  • Antrafenine [INN]

Synonyms

  • 2-(4-(alpha,alpha,alpha-Trifluoro-m-tolyl)-1-piperazinyl)ethyl N-(7-(trifluoromethyl)-4-quinolyl)anthranilate
  • 2-(7-Trifluormethyl-4-chinolylamino)benzoesaeure-2-(4-(3-trifluormethylphenyl)-1-piperazinyl)ethylester
  • 4-(3-Trifluoromethyl)phenylpiperazineethanol o-(7-trifluoromethyl-4-quinolylamino)benzoate
  • Antrafenine
  • Antrafenino
  • Antrafenino [INN-Spanish]
  • Antrafeninum
  • Antrafeninum [INN-Latin]
  • BRN 0600911
  • SL 73-033
  • Stakan
  • Stakane
  • UNII-21FS93Y6OE

Systematic Names

  • 2-(4-(alpha,alpha,alpha-Trifluoro-m-tolyl)-1-piperazinyl)ethyl N-(7-(trifluoromethyl)-4-quinolyl)anthranilate
  • Benzoic acid, 2-((7-(trifluoromethyl)-4-quinolinyl)amino)-, 2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl ester
  • Piperazineethanol, 4-(alpha,alpha,alpha-trifluoro-m-tolyl)-, N-(7-trifluoromethyl-4-quinolyl)anthranilate

Registry Numbers

CAS Registry Number

  • 55300-29-3

FDA UNII

  • 21FS93Y6OE

Related Registry Number

  • 55300-30-6 (di-hydrochloride)

System Generated Number

  • 0055300293

Structure Descriptors

InChI

1S/C30H26F6N4O2/c31-29(32,33)20-4-3-5-22(18-20)40-14-12-39(13-15-40)16-17-42-28(41)24-6-1-2-7-25(24)38-26-10-11-37-27-19-21(30(34,35)36)8-9-23(26)27/h1-11,18-19H,12-17H2,(H,37,38)

InChIKey

NWGGKKGAFZIVBJ-UHFFFAOYSA-N

Smiles

C(F)(F)(F)c1cc2nccc(c2cc1)Nc1c(C(OCCN2CCN(CC2)c2cc(ccc2)C(F)(F)F)=O)cccc1

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 oral 4gm/kg (4000mg/kg) BEHAVIORAL: ANALGESIA Journal of Medicinal Chemistry. Vol. 22, Pg. 554, 1979.